HomeBEAM • NASDAQ
Beam Therapeutics Inc
$33.96
Pre-market:
$33.96
(0.00%)0.00
Closed: Mar 28, 12:30:57 AM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$33.22
Day range
$32.80 - $34.20
Year range
$16.95 - $49.50
Market cap
2.77B USD
Avg Volume
1.53M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
316.19M1,478.04%
Operating expense
43.26M90.72%
Net income
142.80M472.36%
Net profit margin
45.16123.60%
Earnings per share
1.73420.37%
EBITDA
138.22M262.53%
Effective tax rate
0.95%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
1.19B10.36%
Total assets
1.46B8.79%
Total liabilities
478.38M-21.35%
Total equity
981.33M
Shares outstanding
78.73M
Price to book
2.66
Return on assets
24.15%
Return on capital
31.52%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
142.80M472.36%
Cash from operations
135.07M295.22%
Cash from investing
98.10M-13.52%
Cash from financing
33.71M5.31%
Net change in cash
266.88M249.97%
Free cash flow
95.32M278.82%
About
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR and prime editing, whereby single nucleotides in a DNA sequence can be modified without cutting the DNA, theoretically reducing the likelihood of off-target effects compared to previous CRISPR-based methods. Wikipedia
Founded
2017
Website
Employees
436
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu